About International HIFU

International HIFU is a subsidiary of USHIFU, LLC (“US HIFU”), a privately held healthcare company focused on treating diseases, such as prostate cancer, with high intensity focused ultrasound (“HIFU”) technologies. US HIFU was founded in 2004 and is headquartered in Charlotte, N.C. US HIFU manufactures, distributes and manages delivery of care with the Sonablate^® 500 (“Sonablate”) medical device, designed to treat prostate disease with HIFU energy (“Sonablate HIFU”).

International HIFU’s treatment program enables U.S. patients and physicians to gain access to the technology in nearby offshore locations where it is already approved or authorized and available, including Nassau, Bahamas; Cancun and Puerto Vallarta, Mexico; Bermuda; and Toronto, Niagara Falls, Montreal and Winnipeg, Canada. Sonablate HIFU can be found in additional areas such as Argentina, Australia, Brazil, China, Dominican Republic, Europe (Austria, France, Germany, Hungary, Italy, Romania, Russia, Spain, United Kingdom) India, Iran, Japan and Vietnam.

Click here to see where HIFU is available.

Mission
International HIFU is committed to treating prostate cancer using HIFU with the Sonablate^® 500, a minimally invasive, outpatient procedure pioneered to control cancer and significantly improve patients’ quality of life.

Address
International HIFU
801 E. Morehead St
Suite 201
Charlotte, NC 28202
Toll Free from US & Canada: 1-866-553-1629
704-332-4308
704-332-5628 - fax
This e-mail address is being protected from spambots. You need JavaScript enabled to view it.

Careers
No available positions open at this time.